353 related articles for article (PubMed ID: 10206294)
21. [Surgical therapy of stomach cancer--indications for splenectomy in gastrectomy].
Meyer HJ; Jähne J; Weimann A; Pichlmayr R
Chirurg; 1994 May; 65(5):437-40. PubMed ID: 8050297
[TBL] [Abstract][Full Text] [Related]
22. Lymph node dissection around the splenic artery and hilum in advanced middle third gastric carcinoma.
Li C; Kim S; Lai JF; Oh SJ; Hyung WJ; Choi WH; Choi SH; Zhu ZG; Noh SH
Eur J Surg Oncol; 2009 Jul; 35(7):709-14. PubMed ID: 18455906
[TBL] [Abstract][Full Text] [Related]
23. Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer.
Sasada S; Ninomiya M; Nishizaki M; Harano M; Ojima Y; Matsukawa H; Aoki H; Shiozaki S; Ohno S; Takakura N
Anticancer Res; 2009 Aug; 29(8):3347-51. PubMed ID: 19661354
[TBL] [Abstract][Full Text] [Related]
24. Lymph node dissection in resectable advanced gastric cancer.
de Steur WO; Dikken JL; Hartgrink HH
Dig Surg; 2013; 30(2):96-103. PubMed ID: 23867585
[TBL] [Abstract][Full Text] [Related]
25. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer.
Yu W; Choi GS; Chung HY
Br J Surg; 2006 May; 93(5):559-63. PubMed ID: 16607678
[TBL] [Abstract][Full Text] [Related]
26. [Feasibility, safety and long-term efficacy of laparoscopic total gastrectomy combined with distal pancreaticosplenectomy for T4b gastric cancer].
Zhou SN; Yang B; Tan JN; Huang J; Chen ZT; Zheng SY; Gao H; Zhang YC; Wen LQ; Han FH
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):163-169. PubMed ID: 32074797
[No Abstract] [Full Text] [Related]
27. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer.
Shin SH; Jung H; Choi SH; An JY; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Ann Surg Oncol; 2009 May; 16(5):1304-9. PubMed ID: 19241107
[TBL] [Abstract][Full Text] [Related]
28. Lymph node metastasis at the splenic hilum in proximal gastric cancer.
Ikeguchi M; Kaibara N
Am Surg; 2004 Jul; 70(7):645-8. PubMed ID: 15279191
[TBL] [Abstract][Full Text] [Related]
29. The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer.
Oh SJ; Hyung WJ; Li C; Song J; Kang W; Rha SY; Chung HC; Choi SH; Noh SH;
J Surg Oncol; 2009 Apr; 99(5):275-80. PubMed ID: 19152367
[TBL] [Abstract][Full Text] [Related]
30. [Indications for splenectomy in the surgical treatment of gastric cancer].
Bortul M; Guarino G; Calligaris L; Roseano M
Chir Ital; 2001; 53(4):495-503. PubMed ID: 11586568
[TBL] [Abstract][Full Text] [Related]
31. Laparoscopic pancreas- and spleen-preserving D2 lymph node dissection in advanced (cT2) upper-third gastric cancer.
Hur H; Jeon HM; Kim W
J Surg Oncol; 2008 Feb; 97(2):169-72. PubMed ID: 18095269
[TBL] [Abstract][Full Text] [Related]
32. Multi-visceral resection for locally advanced gastric cancer.
Bloechle C; Izbicki JR; Limmer J; Kühn R; Hosch SB; Busch C; Rogiers X; Broelsch CE
Acta Chir Belg; 1995; 95(2):72-5. PubMed ID: 7754735
[TBL] [Abstract][Full Text] [Related]
33. Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival.
Wanebo HJ; Kennedy BJ; Winchester DP; Stewart AK; Fremgen AM
J Am Coll Surg; 1997 Aug; 185(2):177-84. PubMed ID: 9249086
[TBL] [Abstract][Full Text] [Related]
34. Spleen preservation in radical surgery for gastric cardia cancer.
Zhang CH; Zhan WH; He YL; Chen CQ; Huang MJ; Cai SR
Ann Surg Oncol; 2007 Apr; 14(4):1312-9. PubMed ID: 17265118
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic value of splenectomy and lymph-node dissection during gastric cancer resection].
Tammaro V; Carlomagno N; Lombari P; Tedesco G; Renda A
Chir Ital; 2006; 58(2):163-70. PubMed ID: 16734164
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathologic features of the patients with node-negative metastasis gastric adenocarcinoma and their survival analysis].
Li J; Cai SR; He YL; Huang MJ; Mei KY; Wang JP; Zhan WH
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):230-3. PubMed ID: 16721684
[TBL] [Abstract][Full Text] [Related]
37. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
38. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
Bittorf BR; Günther F; Merkel S; Horbach T; Hohenberger W; Günther K
Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
Schmid A; Thybusch A; Kremer B; Henne-Bruns D
Hepatogastroenterology; 2000; 47(32):579-85. PubMed ID: 10791243
[TBL] [Abstract][Full Text] [Related]
40. [Long-term survival of curatively operated gastric cancer: influence of the gender and splenectomy].
Schafmayer C; Jürgens G; Jürgens I; Klomp HJ; Fändrich F; Kahlke V
Zentralbl Chir; 2007 Dec; 132(6):515-22. PubMed ID: 18098079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
